Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

Michael O'Riordan

January 10, 2024

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

A New Biomarker to Diagnose Acute Myocarditis?

Todd Neale

June 03, 2021

News Daily News

‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

Todd Neale

August 17, 2020

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

CVD Still the Leading Cause of Death and Disease Globally

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

Reduced EF Evident in Some Elite Endurance Athletes

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

A New Biomarker to Diagnose Acute Myocarditis?

‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content